The Derms on Drugs Take on Big Questions

-Big BCCs – Debulk First or Chemo First?; 

-Do Covid or the Covid Vaccine Affect the Risk of Getting a Bullous Disease?

-Does Drinking Drive Melasma?

But of course that’s not all: Should we be treating Strep to help our psoriasis patients get better faster? What Biologics are new on the horizon for treating linear morphea? And just how well does oral roflumilast work for psoriasis?

Join us this week for more dermatology takes that you won’t get anywhere else!

Derms on Drugs is brought to you by ⁠Scholars in Medicine.

Resource links for this episode are available at Scholars in Medicine.

1. Surgical Debulking Modifies Notch Signaling and May Improve Vismodegib Effectiveness for Locally Advanced Basal Cell Carcinoma
2. COVID-19 infection is associated with an elevated risk for autoimmune blistering diseases while COVID-19 vaccination decreases the risk: A large-scale population-based cohort study of 112 million individuals
3. Diet and Living Environment as Novel Etiological Factors for Melasma: The Results Form a Retrospective Case-Control Study of 150 Chinese Patients
4. The impact of antibiotic therapy in psoriasis patients with active streptococcal infection: A prospective study
5. Use of biologic drug in the treatment of localized scleroderma and systemic sclerosis in children: A scoping review
6. Oral roflumilast for psoriasis: a real-world 24-week prospective cohort study
7. A randomized, controlled pilot study of oral roflumilast compared with intramuscular methotrexate for plaque and scalp psoriasis
8. Roflumilast and cognition enhancement: A translational perspective
9. Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: a double-blind placebo-controlled study
10. Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults